| T1015 | Clinic visit/encounter, all-inclusive | 188,330 | $280 | $52.9M |
| 00003 | N/A | 25,380 | $330 | $8.3M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 67,830 | $10 | $542.6K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which… | 7,600 | $60 | $478.7K |
| 96110 | The provider screens the patient for a developmental disorder using a standardized instrument (such as a recognized form) focused on areas such as developmental milestones and age–appropriate… | 5,650 | $40 | $214.7K |
| 90750 | The provider injects an adjuvanted vaccine into a muscle to protect the patient against varicella zoster infection. | 1,350 | $150 | $204.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 27,670 | $10 | $193.7K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 5,380 | $40 | $193.6K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,030 | $170 | $177K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 750 | $140 | $103.4K |